Immune cells from 4T1.2/HER2 tumor-bearing and tumor-regressed mice produced IFN-γ in response to HER2 class I peptides, while those from CT26/HER2 tumor-bearing mice produced extremely high levels of IFN-γ independent of HER2 class I peptide stimulation. The gene discussed is ERBB2; the disease is neoplasm.